Guru Ownership Trend
Guru Analysis for Vera Therapeutics, Inc. (VERA)
Vera Therapeutics, Inc. (VERA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $71.5 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $10.29 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 136.5%. Conversely, Steven Cohen reduced exposure by 30.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Vera Therapeutics, Inc. (VERA)
Major holders include Steven Cohen ($48.71 M), Renaissance Technologies (RenTech) ($18.4 M), Cliff Asness ($644,001). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.68 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $10.29 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited VERA. The total reported sell value was $21.23 M.
Yes, 0 managers opened new positions in VERA, and 2 increased their existing holdings. The total reported buy value was $10.94 M.